Article
What's New in Genetic Testing for Cancer Susceptibility?
Oncology (Williston Park, N.Y.) - 15 Sept 2016
Plichta Jennifer K, Griffin Molly, Thakuria Joseph, Hughes Kevin S
Abstract excerpt
The advent of next-generation sequencing, and its transition further into the clinic with the US Food and Drug Administration approval of a cystic fibrosis assay in 2013, have increased the speed and reduced the cost of DNA sequencing. Coupled with a historic ruling by the Supreme Court of the United States that human genes are not patentable, these events have caused a seismic shift in genetic testing in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
